TickerLeague

Gross Profit for AbbVie (ABBV)

According to AbbVie's latest reported financial statements, the company's current gross profit (TTM) is $42.96B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

AbbVie Inc. logo
AbbVie

ABBV

TTM (last 4 quarters)

$42.96B

YoY change

+8.9%

5Y CAGR

+7.1%

Peak year (2025)

$42.96B

Cumulative gross profit

$414.22B

Gross Profit history chart for AbbVie (ABBV) from 2009 to 2025

Gross Profit history table for AbbVie (ABBV) from 2009 to 2025

Fiscal yearPeriod endedReportedGross ProfitYoY
2025$42.96B+8.9%
2024$39.43B+16.3%
2023$33.90B-16.6%
2022$40.64B+4.9%
2021$38.75B+27.4%
2020$30.42B+17.8%
2019$25.83B+3.2%
2018$25.04B+18.2%
2017$21.18B+6.9%
2016$19.80B+7.9%
2015$18.36B+18.2%
2014$15.53B+9.3%
2013$14.21B+2.4%
2012$13.87B+8.3%
2011$12.80B+12.9%
2010$11.35B+11.7%
2009$10.16B

Gross Profit values are taken from AbbVie's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

In 2025, AbbVie (ABBV) gross profit totalled $42.96B – grew 8.9% year-over-year.

Looking at the 2020–2025 (5 years) stretch, AbbVie gross profit compounded at +7.1% per year, sustaining 2 straight years of year-over-year growth.

$42.96B stands as the all-time-high annual gross profit, posted in 2025, against a low of $10.16B during 2009.

AbbVie (ABBV) sits 7th of 8 Healthcare peers we track on this metric, against a peer median of $53.80B.

AbbVie Gross Profit by Year

AbbVie Gross Profit 2025: $42.96B

AbbVie gross profit in 2025 was $42.96B, grew 8.9% from 2024. This figure represents the highest annual value in the available history.

AbbVie Gross Profit 2024: $39.43B

AbbVie gross profit in 2024 was $39.43B, grew 16.3% from 2023.

AbbVie Gross Profit 2023: $33.90B

AbbVie gross profit in 2023 was $33.90B, declined 16.6% below 2022.

AbbVie Gross Profit 2022: $40.64B

AbbVie gross profit in 2022 was $40.64B, edged up 4.9% from 2021.

AbbVie Gross Profit 2021: $38.75B

AbbVie gross profit in 2021 was $38.75B.

See more financial history for AbbVie (ABBV).

Sector peers — Gross Profit

Companies in the same sector as AbbVie, ranked by their latest gross profit.

CompanyGross ProfitSector
Novo Nordisk A/S (NVO)$250.28BHealthcare
UnitedHealth Group Incorporated (UNH)$82.92BHealthcare
Johnson & Johnson (JNJ)$68.56BHealthcare
Eli Lilly and Company (LLY)$54.62BHealthcare
Merck & Co., Inc. (MRK)$52.98BHealthcare
AstraZeneca PLC (AZN)$48.11BHealthcare
Amgen Inc. (AMGN)$26.01BHealthcare
Thermo Fisher Scientific Inc. (TMO)$16.78BHealthcare

Frequently asked questions

What is AbbVie's gross profit?

Latest reported gross profit for AbbVie (ABBV) is $42.96B (period ending December 31, 2025).

How has AbbVie gross profit changed year-over-year?

AbbVie (ABBV) gross profit changed +8.9% year-over-year on the latest annual filing.

What is the long-term growth rate of AbbVie gross profit?

AbbVie (ABBV) gross profit compound annual growth rate is +7.1% over the most recent 5 years available.

When did AbbVie gross profit hit its highest annual value?

AbbVie gross profit reached its highest annual value of $42.96B in 2025.

What was AbbVie gross profit in 2024?

AbbVie (ABBV) gross profit in 2024 was $39.43B.

What was AbbVie gross profit in 2025?

AbbVie (ABBV) gross profit in 2025 was $42.96B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.